scPharmaceuticals CEO John Tucker's 2022 pay slips 14% to $1.6M

scPharmaceuticals reports 2022 executive compensation

By ExecPay News

Published: April 27, 2023

scPharmaceuticals reported fiscal year 2022 executive compensation information on April 27, 2023.
In 2022, two executives at scPharmaceuticals received on average a compensation package of $1.3M, a 2% increase compared to previous year.
Average pay of disclosed executives at scPharmaceuticals
John H. Tucker, Chief Executive Officer, received $1.6M in total, which decreased by 14% compared to 2021. 43% of Tucker's compensation, or $683K, was in option awards. Tucker also received $319K in non-equity incentive plan, $580K in salary, as well as $13K in other compensation.
Rachael Nokes, Chief Financial Officer, received a compensation package of $1.1M, which increased by 46% compared to previous year. 53% of the compensation package, or $554K, was in option awards.

Related executives

John Tucker

scPharmaceuticals

Chief Executive Officer

Rachael Nokes

scPharmaceuticals

Chief Financial Officer

You may also like

Source: SEC filing on April 27, 2023.